Anhydrate to hydrate solid-state transformations of carbamazepine and nitrofurantoin in biorelevant media studied in situ using time-resolved synchrotron X-ray diffraction

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Anhydrate to hydrate solid-state transformations of carbamazepine and nitrofurantoin in biorelevant media studied in situ using time-resolved synchrotron X-ray diffraction. / Bøtker, Johan Peter; Rantanen, Jukka; Arnfast, Lærke; Doreth, Maria; Raijada, Dharaben Kaushikkumar; Löbmann, Korbinian; Madsen, Cecilie Maria; Khan, Jamal; Rades, Thomas; Müllertz, Anette; Hawley, Adrian; Thomas, Diana; Boyd, Ben J.

In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 100, 03.2016, p. 119-127.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Bøtker, JP, Rantanen, J, Arnfast, L, Doreth, M, Raijada, DK, Löbmann, K, Madsen, CM, Khan, J, Rades, T, Müllertz, A, Hawley, A, Thomas, D & Boyd, BJ 2016, 'Anhydrate to hydrate solid-state transformations of carbamazepine and nitrofurantoin in biorelevant media studied in situ using time-resolved synchrotron X-ray diffraction', European Journal of Pharmaceutics and Biopharmaceutics, vol. 100, pp. 119-127. https://doi.org/10.1016/j.ejpb.2016.01.004

APA

Bøtker, J. P., Rantanen, J., Arnfast, L., Doreth, M., Raijada, D. K., Löbmann, K., ... Boyd, B. J. (2016). Anhydrate to hydrate solid-state transformations of carbamazepine and nitrofurantoin in biorelevant media studied in situ using time-resolved synchrotron X-ray diffraction. European Journal of Pharmaceutics and Biopharmaceutics, 100, 119-127. https://doi.org/10.1016/j.ejpb.2016.01.004

Vancouver

Bøtker JP, Rantanen J, Arnfast L, Doreth M, Raijada DK, Löbmann K et al. Anhydrate to hydrate solid-state transformations of carbamazepine and nitrofurantoin in biorelevant media studied in situ using time-resolved synchrotron X-ray diffraction. European Journal of Pharmaceutics and Biopharmaceutics. 2016 Mar;100:119-127. https://doi.org/10.1016/j.ejpb.2016.01.004

Author

Bøtker, Johan Peter ; Rantanen, Jukka ; Arnfast, Lærke ; Doreth, Maria ; Raijada, Dharaben Kaushikkumar ; Löbmann, Korbinian ; Madsen, Cecilie Maria ; Khan, Jamal ; Rades, Thomas ; Müllertz, Anette ; Hawley, Adrian ; Thomas, Diana ; Boyd, Ben J. / Anhydrate to hydrate solid-state transformations of carbamazepine and nitrofurantoin in biorelevant media studied in situ using time-resolved synchrotron X-ray diffraction. In: European Journal of Pharmaceutics and Biopharmaceutics. 2016 ; Vol. 100. pp. 119-127.

Bibtex

@article{b50e3d49d5364f8cab75c9aad51cf3da,
title = "Anhydrate to hydrate solid-state transformations of carbamazepine and nitrofurantoin in biorelevant media studied in situ using time-resolved synchrotron X-ray diffraction",
abstract = "Abstract Transformation of the solid-state form of a drug compound in the lumen of the gastrointestinal tract may alter the drug bioavailability and in extreme cases result in patient fatalities. The solution-mediated anhydrate-to-hydrate phase transformation was examined using an in vitro model with different biorelevant media, simulated fasted and fed state intestinal fluids containing bile salt and dioleoylphosphatidylcholine (DOPC) micelles, DOPC/sodium dodecyl sulfate (SDS) mixture, bile salt solution and water. Two anhydrate compounds (carbamazepine, CBZ and nitrofurantoin, NF) with different overall transformation time into hydrate form were used as model compounds. The transformations were monitored using direct structural information from time-resolved synchrotron X-ray diffraction. The kinetics of these transformations were estimated using multivariate data analysis (principal component analysis, PCA) and compared to those for nitrofurantoin (NF). The study showed that the solution-mediated phase transformation of CBZ anhydrate was remarkably faster in the DOPC/SDS medium compared to transformation in all the other aqueous dispersion media. The conversion time for CBZ anhydrate in water was shorter than for DOPC/SDS but still faster than the conversion seen in fed and fasted state micellar media. The conversion of CBZ anhydrate to hydrate was the slowest in the solution containing bile salt alone. In contrast, the solution-mediated phase transformations of NF did only show limited kinetic dependence on the dispersion media used, indicating the complexity of the nucleation process. Furthermore, when the CBZ and NF material was compacted into tablets the transformation times were remarkably slower. Results suggest that variations in the composition of the contents of the stomach/gut may affect the recrystallization kinetics, especially when investigating compounds with relatively fast overall transformation time, such as CBZ.",
keywords = "Carbamazepine, Nitrofurantoin, Solution-mediated transformation, Synchrotron, PCA, Micelles",
author = "B{\o}tker, {Johan Peter} and Jukka Rantanen and L{\ae}rke Arnfast and Maria Doreth and Raijada, {Dharaben Kaushikkumar} and Korbinian L{\"o}bmann and Madsen, {Cecilie Maria} and Jamal Khan and Thomas Rades and Anette M{\"u}llertz and Adrian Hawley and Diana Thomas and Boyd, {Ben J.}",
year = "2016",
month = "3",
doi = "10.1016/j.ejpb.2016.01.004",
language = "English",
volume = "100",
pages = "119--127",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Anhydrate to hydrate solid-state transformations of carbamazepine and nitrofurantoin in biorelevant media studied in situ using time-resolved synchrotron X-ray diffraction

AU - Bøtker, Johan Peter

AU - Rantanen, Jukka

AU - Arnfast, Lærke

AU - Doreth, Maria

AU - Raijada, Dharaben Kaushikkumar

AU - Löbmann, Korbinian

AU - Madsen, Cecilie Maria

AU - Khan, Jamal

AU - Rades, Thomas

AU - Müllertz, Anette

AU - Hawley, Adrian

AU - Thomas, Diana

AU - Boyd, Ben J.

PY - 2016/3

Y1 - 2016/3

N2 - Abstract Transformation of the solid-state form of a drug compound in the lumen of the gastrointestinal tract may alter the drug bioavailability and in extreme cases result in patient fatalities. The solution-mediated anhydrate-to-hydrate phase transformation was examined using an in vitro model with different biorelevant media, simulated fasted and fed state intestinal fluids containing bile salt and dioleoylphosphatidylcholine (DOPC) micelles, DOPC/sodium dodecyl sulfate (SDS) mixture, bile salt solution and water. Two anhydrate compounds (carbamazepine, CBZ and nitrofurantoin, NF) with different overall transformation time into hydrate form were used as model compounds. The transformations were monitored using direct structural information from time-resolved synchrotron X-ray diffraction. The kinetics of these transformations were estimated using multivariate data analysis (principal component analysis, PCA) and compared to those for nitrofurantoin (NF). The study showed that the solution-mediated phase transformation of CBZ anhydrate was remarkably faster in the DOPC/SDS medium compared to transformation in all the other aqueous dispersion media. The conversion time for CBZ anhydrate in water was shorter than for DOPC/SDS but still faster than the conversion seen in fed and fasted state micellar media. The conversion of CBZ anhydrate to hydrate was the slowest in the solution containing bile salt alone. In contrast, the solution-mediated phase transformations of NF did only show limited kinetic dependence on the dispersion media used, indicating the complexity of the nucleation process. Furthermore, when the CBZ and NF material was compacted into tablets the transformation times were remarkably slower. Results suggest that variations in the composition of the contents of the stomach/gut may affect the recrystallization kinetics, especially when investigating compounds with relatively fast overall transformation time, such as CBZ.

AB - Abstract Transformation of the solid-state form of a drug compound in the lumen of the gastrointestinal tract may alter the drug bioavailability and in extreme cases result in patient fatalities. The solution-mediated anhydrate-to-hydrate phase transformation was examined using an in vitro model with different biorelevant media, simulated fasted and fed state intestinal fluids containing bile salt and dioleoylphosphatidylcholine (DOPC) micelles, DOPC/sodium dodecyl sulfate (SDS) mixture, bile salt solution and water. Two anhydrate compounds (carbamazepine, CBZ and nitrofurantoin, NF) with different overall transformation time into hydrate form were used as model compounds. The transformations were monitored using direct structural information from time-resolved synchrotron X-ray diffraction. The kinetics of these transformations were estimated using multivariate data analysis (principal component analysis, PCA) and compared to those for nitrofurantoin (NF). The study showed that the solution-mediated phase transformation of CBZ anhydrate was remarkably faster in the DOPC/SDS medium compared to transformation in all the other aqueous dispersion media. The conversion time for CBZ anhydrate in water was shorter than for DOPC/SDS but still faster than the conversion seen in fed and fasted state micellar media. The conversion of CBZ anhydrate to hydrate was the slowest in the solution containing bile salt alone. In contrast, the solution-mediated phase transformations of NF did only show limited kinetic dependence on the dispersion media used, indicating the complexity of the nucleation process. Furthermore, when the CBZ and NF material was compacted into tablets the transformation times were remarkably slower. Results suggest that variations in the composition of the contents of the stomach/gut may affect the recrystallization kinetics, especially when investigating compounds with relatively fast overall transformation time, such as CBZ.

KW - Carbamazepine

KW - Nitrofurantoin

KW - Solution-mediated transformation

KW - Synchrotron

KW - PCA

KW - Micelles

U2 - 10.1016/j.ejpb.2016.01.004

DO - 10.1016/j.ejpb.2016.01.004

M3 - Journal article

VL - 100

SP - 119

EP - 127

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

SN - 0939-6411

ER -

ID: 160046355